{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:30:52Z","timestamp":1793136652625,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,8]],"date-time":"2015-01-08T00:00:00Z","timestamp":1420675200000},"content-version":"vor","delay-in-days":372,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuron"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.neuron.2013.10.061","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T10:31:42Z","timestamp":1389177102000},"page":"49-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":599,"title":["Increased Brain Penetration and Potency of a Therapeutic Antibody Using a Monovalent Molecular Shuttle"],"prefix":"10.1016","volume":"81","author":[{"given":"Jens","family":"Niewoehner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Bohrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"Collin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Urich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadassah","family":"Sade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Rueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan\u00a0Olaf","family":"Stracke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilma","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain\u00a0C.","family":"Tissot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hansruedi","family":"Loetscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anirvan","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per-Ola","family":"Freskg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuron.2013.10.061_bib1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3233\/JAD-2011-110977","article-title":"Gantenerumab: a novel human anti-A\u03b2 antibody demonstrates sustained cerebral amyloid-\u03b2 binding and elicits cell-mediated removal of human amyloid-\u03b2","volume":"28","author":"Bohrmann","year":"2012","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuron.2013.10.061_bib2","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.1158\/0008-5472.CAN-10-0938","article-title":"Development of human\u00a0single-chain antibodies to the transferrin receptor that effectively antagonize the growth of leukemias and lymphomas","volume":"70","author":"Cr\u00e9pin","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.neuron.2013.10.061_bib3","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1097\/01.WCB.0000135592.28823.47","article-title":"Targeting anti-transferrin receptor antibody (OX26) and OX26-conjugated liposomes to brain capillary endothelial cells using in\u00a0situ perfusion","volume":"24","author":"Gosk","year":"2004","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neuron.2013.10.061_bib4","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/ncb2652","article-title":"A human genome-wide screen for regulators of clathrin-coated vesicle formation reveals an unexpected role for the V-ATPase","volume":"15","author":"Kozik","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.neuron.2013.10.061_bib5","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.cell.2005.12.038","article-title":"Ligands for clathrin-mediated endocytosis are differentially sorted into distinct populations of early endosomes","volume":"124","author":"Lakadamyali","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.neuron.2013.10.061_bib6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/84859","article-title":"Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice","volume":"27","author":"LaVaute","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuron.2013.10.061_bib7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0014-4827(89)90293-0","article-title":"Modulation of transferrin receptor expression and function by anti-transferrin receptor antibodies and antibody fragments","volume":"182","author":"Lesley","year":"1989","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.neuron.2013.10.061_bib8","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/7727","article-title":"Transferrin receptor is necessary for development of erythrocytes and the nervous system","volume":"21","author":"Levy","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuron.2013.10.061_bib9","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1083\/jcb.201008117","article-title":"Local clustering of transferrin receptors promotes clathrin-coated pit initiation","volume":"191","author":"Liu","year":"2010","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.neuron.2013.10.061_bib10","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/j.1600-0854.2011.01240.x","article-title":"Small GTPase Rab12 regulates constitutive degradation of transferrin receptor","volume":"12","author":"Matsui","year":"2011","journal-title":"Traffic"},{"key":"10.1016\/j.neuron.2013.10.061_bib11","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1002\/ijc.27811","article-title":"Inhibitors of vacuolar ATPase proton pumps inhibit human prostate cancer cell invasion and prostate-specific antigen expression and secretion","volume":"132","author":"Michel","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.neuron.2013.10.061_bib12","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1212\/WNL.0b013e31826e2696","article-title":"Indicators of amyloid burden in a population-based study of cognitively normal elderly","volume":"79","author":"Mielke","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neuron.2013.10.061_bib13","doi-asserted-by":"crossref","first-page":"E471","DOI":"10.1073\/pnas.1115495109","article-title":"Rabenosyn-5 defines the fate of the transferrin receptor following clathrin-mediated endocytosis","volume":"109","author":"Navaroli","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2013.10.061_bib14","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","article-title":"Drug transport across the blood-brain barrier","volume":"32","author":"Pardridge","year":"2012","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neuron.2013.10.061_bib15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/B978-0-12-396962-0.00011-2","article-title":"Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier","volume":"503","author":"Pardridge","year":"2012","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.neuron.2013.10.061_bib16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1124\/mol.111.071027","article-title":"In\u00a0vivo labeling of brain capillary endothelial cells after intravenous injection of monoclonal antibodies targeting the transferrin receptor","volume":"80","author":"Paris-Robidas","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuron.2013.10.061_bib17","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1073\/pnas.91.12.5705","article-title":"Macromolecular permeability across the blood-nerve and blood-brain barriers","volume":"91","author":"Poduslo","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2013.10.061_bib18","doi-asserted-by":"crossref","first-page":"8989","DOI":"10.1523\/JNEUROSCI.23-26-08989.2003","article-title":"PS2APP transgenic mice, coexpressing hPS2mut and hAPPswe, show age-related cognitive deficits associated with discrete brain amyloid deposition and inflammation","volume":"23","author":"Richards","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuron.2013.10.061_bib19","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1172\/JCI44798","article-title":"Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma","volume":"121","author":"Staquicini","year":"2011","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.neuron.2013.10.061_bib20","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1021\/mp400004a","article-title":"Pharmacokinetics and brain uptake of an IgG-TNF decoy receptor fusion protein following intravenous, intraperitoneal, and subcutaneous administration in mice","volume":"10","author":"Sumbria","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.neuron.2013.10.061_bib21","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1073\/pnas.1222742110","article-title":"Engineering a lysosomal enzyme with a derivative of receptor-binding domain of apoE enables delivery across the blood-brain barrier","volume":"110","author":"Wang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2013.10.061_bib22","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1096\/fj.04-3458fje","article-title":"Blood-brain barrier-specific properties of a human adult brain endothelial cell line","volume":"19","author":"Weksler","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.neuron.2013.10.061_bib23","doi-asserted-by":"crossref","first-page":"84ra44","DOI":"10.1126\/scitranslmed.3002230","article-title":"Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target","volume":"3","author":"Yu","year":"2011","journal-title":"Sci. Transl. Med."}],"container-title":["Neuron"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896627313010350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896627313010350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T20:35:50Z","timestamp":1565037350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896627313010350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0896627313010350"],"URL":"https:\/\/doi.org\/10.1016\/j.neuron.2013.10.061","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718235729.793495584","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.718235729.793494670","asserted-by":"object"}]},"ISSN":["0896-6273"],"issn-type":[{"value":"0896-6273","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased Brain Penetration and Potency of a Therapeutic Antibody Using a Monovalent Molecular Shuttle","name":"articletitle","label":"Article Title"},{"value":"Neuron","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuron.2013.10.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.neuron.2013.12.023","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}